This opportunity is no longer accepting applications.
grant
Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
This grant opportunity aims to support research focused on understanding and enhancing long-lasting immune responses to potential HIV vaccines.
Source
Agency: National Institutes of Health
Program: SBIR
Award
Award Ceiling: $750,000
Funding Amount: $750,000
Dates
Opportunity Released: April 25, 2024
Open for Submission: April 25, 2024
Submission Deadline: October 9, 2024
Application Window Closes: October 9, 2024
Keywords
HIV
vaccine
immune response
research
durability
applied research
basic research
funding
clinical trial
NOFO
Supporting Links
Sign up to unlock the source links
Sign up freeDocuments
Sign up to unlock the solicitation documents
Sign up freeSimilar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers